APA ציטוט

Portelinha, A., Thompson, S., Smith, R. A., Da Silva Ferreira, M., Asgari, Z., Knezevic, A., . . . Reddy, S. (2021). ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors. Cell Rep Med.

Citação norma Chicago

Portelinha, Ana, et al. "ASN007 Is a Selective ERK1/2 Inhibitor With Preferential Activity against RAS-and RAF-mutant Tumors." Cell Rep Med 2021.

ציטוט MLA

Portelinha, Ana, et al. "ASN007 Is a Selective ERK1/2 Inhibitor With Preferential Activity against RAS-and RAF-mutant Tumors." Cell Rep Med 2021.